The Effect of Passive Smoking on Total Antioxidant Capacity of Serum and Saliva in Rats

Objective: Active and passive smoking lead to the production of a number of oxidants and antioxidants with various adverse health effects compromising the immune system. Tobacco use increases the production of free radicals as well. The purpose of this study was to determine the effects of passive smoking on total antioxidant capacity (TAC) of serum and saliva in rats.Methods: This experimental study was conducted on 18 rats with an age range of 7-11 weeks weighing 160-200 g; 9 of them were exposed to cigarette smoke 3 times daily for 8 minutes. The 9 controls were not exposed to cigarette smoke. After injection of 0.2 mg/kg midazolam and 0.5  mg/kg pilocarpine, serum and saliva samples were taken from subjects in the exposure and control groups at 0, 15 and 30 days. Serum cotinine was measured using ELISA kit. TAC of saliva and serum was measured using ferric reducing antioxidant power (FRAP) assay. TAC values at different time points were statistically analyzed in each group using Repeated Measures ANOVA and compared between the two groups using t-test.Results: At baseline, no significant difference existed between the two groups in terms of serum cotinine concentration but at days 15 and 30, cotinine serum concentration significantly increased in the exposure group. At baseline and 30 days, no significant difference existed between the two groups of passive smoker and non-smoker in terms of serum TAC values but at day 15, serum TAC values were significantly higher in the exposure group. Also, TAC of salivawas significantly higher in the passive smoker group at baseline and at day 15 but at day 30, the difference in this respect between the two groups was not statistically significant.Conclusion: Based on the obtained results, changes in TAC of serum and saliva in rats due to exposure to cigarette smoke were compensated by their immune system activity. However, further investigations are still required in this respect

Periodontal Status in Osteoporotic Postmenopausal Women in Amirkola, North of Iran

Background and purpose: Osteoporosis and periodontitis are two diseases associated with bone loss and are common among postmenopausal women. There are many contradictory results on the effect of osteoporosis on periodontal tissue. This study aimed to determine the association between osteoporosis and periodontal status in postmenopausal women. Materials and methods: This cross-sectional study was part of the second phase of the Amir kola Health and Aging Project (AHAP), in which 210 postmenopausal women were randomly divided into three groups (n=70 per group); normal bone density group,  osteopenic group, and osteoporotic group. Periodontal status was measured using Periodontal Disease Index (PDI), Plaque Index (PI), and Simplified Oral Hygiene Index (OHI-S). Bone mineral density (BMD) was measured by Dual-energy X-ray absorptiometry (DEXA). Data were analyzed in SPSS V17 applying ANOVA, Kruskal-Wallis, and Pearson correlation coefficient. Results: The average age of the participants was 65.24±4.36 years. There were no statistically significant differences between the mean OHI (2.26±1.40), PDI (2.76±1.42), and PI (1.23±0.87) in the osteoporotic group, and the mean OHI (2.01±1.62), PDI (2.56±1.61), and PI (1.35±0.91) in the osteopenia group, and mean OHI (1.73±1.37), PDI (2.47±1.43), and PI (1.23±0.87) in the normal group (P>0.05). The OHI, PDI, and PI had a slight but insignificant negative correlation with BMD. Conclusion: According to this study, there is no link between osteoporosis and periodontal status in postmenopausal women

The association between Antihypertensive drugs and oral health- related quality of life in the elderly: results of Amirkola cohort study

Background: Hypertension is one of the most common chronic diseases in the world. The prevalence of hypertension in the elderly is increasing. Patients with high blood pressure have to take medication throughout their lives. In this study, the relationship between antihypertensive drugs and oral health-related quality of life in the elderly was evaluated. Methods: This modified cross-sectional study, which is the part of the second phase of the Amirkola Health and Ageing Project (AHAP), was performed on 900 elderly people. Participants included 300 people with hypertension under medical treatment, 300 people with hypertension without medication and 300 people with normal blood pressure. All patients’ blood pressure was recorded, and the standard xerostomia questionnaire and GOHAI questionnaire (Geriatric Oral Health Assessment Index) was completed for all participants. Then, the obtained data were analyzed by SPSS 17, whereby student’s t-test, ANOVA and chi square, Pearson correlation coefficient and logistic regression model were used. A p<0.05 was considered statistically significant. Results: The mean GOHAI score in the three studied groups: hypertensive under medication treatment, hypertensive without medication treatment and normal blood pressure (51.1±7.4, 51.7±7.3, 51.1±7.5, respectively) did not differ significantly (P=0.533).The frequency of xerostomia was significantly different in the three groups (P=0.008). Among the antihypertensive drugs, the highest rate of xerostomia was due to the use of calcium channel blockers (31.1) and diuretics (26.8). Conclusion: In our study, although antihypertensive medications were associated with xerostomia, they did not decrease the oral health-related quality of life